Home » Entertainment » Dobol B Sa News TV, RiteMed team up in bringing quality service to Filipinos

Dobol B Sa News TV, RiteMed team up in bringing quality service to Filipinos

Two of the most trusted names in their respective fields come together as GMA Network’s morning news and commentary program, “Dobol B Sa News TV’” and the country’s most trusted brand of medicine, RiteMed Philippines, Inc. (RiteMed) team up to further provide quality service to Filipinos.

Following the program’s successful debut last April 24, “Dobol B sa News TV’” is the Network’s response to the ever-changing needs of the listening and viewing public, bringing to free TV the top-rating morning shows on AM radio today. RiteMed, on the other hand, has always believed in DZBB’s credibility as a trusted source of news and information. In fact, RiteMed is the first company to give its full support to “Dobol B Sa News TV’”.

To formalize this strong and meaningful partnership, the representatives of both parties have inked a Memorandum of Agreement (MOA) on May 4 at the B Hotel Grand Ballroom in Quezon City. The signing was led by RGMA President and GMA Consultant for Radio Mike Enriquez and Dobol B sa News TV anchors Joel Reyes Zobel and GMA News Pillar Arnold Clavio together with United Laboratories, Inc. Senior Vice President for Business Development Atty. Joey Ochave and RiteMed General Manager Vincent Patrick Guerrero.

This tie-up clearly reflects GMA’s mandate of Serbisyong Totoo and RiteMed’s commitment of making medicines more accessible to the public with their tagline, “Dahil gusto naming gumaling kayo”.

“Dobol B Sa News TV’” sees the powerhouse tandem of GMA’s flagship AM radio station DZBB and the country’s leading local news channel GMA News TV. It is headlined by four of the most trusted radio broadcasters in the country – GMA News pillars Mike Enriquez and Arnold Clavio, with Joel Reyes Zobel and Ali Sotto. Together, they bring the latest news and meaty commentaries through Saksi sa Dobol B, Super Balita sa Umaga Nationwide, Sino?, and Dobol A sa Dobol B.

comments